Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$106K Buy
18,575
+2,223
+14% +$9.61K ﹤0.01% 1720
2026
Q1
$63.3K Buy
16,352
+2,161
+15% +$8.87K ﹤0.01% 1619
2025
Q4
$59.3K Buy
14,191
+2,496
+21% +$9.66K ﹤0.01% 1509
2025
Q3
$38.5K Buy
11,695
+149
+1% +$421 ﹤0.01% 1501
2025
Q2
$16.4K Buy
+11,546
New +$16.4K ﹤0.01% 1502

Other funds holding PGEN

Xponance's PGEN Position: Q2 2026 in Review

Xponance increased its Precigen (PGEN) stake by 14% in Q2 2026, buying an estimated $9.61K and bringing the position to 18,575 shares worth $106K. The position accounts for ﹤0.01% of the portfolio, ranked #1720.

Xponance first reported a position in PGEN in Q2 2025 and has held it in 5 quarters since. 211 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.

  • Xponance held 18,575 shares of Precigen worth $106K as of Q2 2026.
  • Xponance bought 2,223 Precigen shares in Q2 2026, an estimated $9.61K.
  • Precigen made up ﹤0.01% of Xponance's portfolio in Q2 2026, its #1720 holding.
  • Xponance first reported a position in Precigen in Q2 2025 and has held it in 5 quarters since.
  • 211 funds tracked by Wall St. Rank held Precigen as of Q2 2026.

Based on Xponance's 13F filing for Q2 2026, filed 10 Aug 2026.